Literature DB >> 11133357

Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study.

C Gaspar1, I Lopes-Cendes, S Hayes, J Goto, K Arvidsson, A Dias, I Silveira, P Maciel, P Coutinho, M Lima, Y X Zhou, B W Soong, M Watanabe, P Giunti, G Stevanin, O Riess, H Sasaki, M Hsieh, G A Nicholson, E Brunt, J J Higgins, M Lauritzen, L Tranebjaerg, V Volpini, N Wood, L Ranum, S Tsuji, A Brice, J Sequeiros, G A Rouleau.   

Abstract

Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder originally described in families of Portuguese-Azorean ancestry. The cloning of the MJD1 gene allowed identification of the disease in many other populations, and MJD is now known to be the most common cause of dominant spinocerebellar ataxia. The hypothesis that its present world distribution could result from the spread of an original founder mutation has been raised, both at historical and molecular levels. In the present study, we tested this hypothesis by linkage-disequilibrium analysis of tightly linked polymorphisms and by haplotype comparison, in 249 families from different countries. We typed five microsatellite markers surrounding the MJD1 locus (D14S1015, D14S995, D14S973, D14S1016, and D14S977), and three intragenic single-base-pair polymorphisms (A(669)TG/G(669)TG, C(987)GG/G(987)GG, and TAA(1118)/TAC(1118)). The results show two different haplotypes, specific to the island of origin, in families of Azorean extraction. In families from mainland Portugal, both Azorean haplotypes can be found. The majority of the non-Portuguese families also share the same intragenic haplotype seen in the families coming from the island of Flores, but at least three other haplotypes were seen. These findings suggest two introductions of the mutation into the Portuguese population. Worldwide, the sharing of one intragenic haplotype by the majority of the families studied implies a founder mutation in MJD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11133357      PMCID: PMC1235286          DOI: 10.1086/318184

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

Review 1.  Machado-Joseph disease gene products carrying different carboxyl termini.

Authors:  J Goto; M Watanabe; Y Ichikawa; S B Yee; N Ihara; K Endo; S Igarashi; Y Takiyama; C Gaspar; P Maciel; S Tsuji; G A Rouleau; I Kanazawa
Journal:  Neurosci Res       Date:  1997-08       Impact factor: 3.304

2.  A comparison of linkage disequilibrium measures for fine-scale mapping.

Authors:  B Devlin; N Risch
Journal:  Genomics       Date:  1995-09-20       Impact factor: 5.736

3.  Linkage disequilibrium between the spinocerebellar ataxia 3/Machado-Joseph disease mutation and two intragenic polymorphisms, one of which, X359Y, affects the stop codon.

Authors:  G Stevanin; A S Lebre; C Mathieux; G Cancel; N Abbas; O Didierjean; A Dürr; Y Trottier; Y Agid; A Brice
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

4.  Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia. A unique and partially treatable clinico-pathological entity.

Authors:  B T Woods; H H Schaumburg
Journal:  J Neurol Sci       Date:  1972-10       Impact factor: 3.181

5.  Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts.

Authors:  K K Nakano; D M Dawson; A Spence
Journal:  Neurology       Date:  1972-01       Impact factor: 9.910

6.  Linkage disequilibrium analysis in Machado-Joseph disease patients of different ethnic origins.

Authors:  C Gaspar; I Lopes-Cendes; A L DeStefano; P Maciel; I Silveira; P Coutinho; P MacLeod; J Sequeiros; L A Farrer; G A Rouleau
Journal:  Hum Genet       Date:  1996-11       Impact factor: 4.132

7.  Machado-Joseph disease mutations as the genetic basis of most spinocerebellar ataxias in Germany.

Authors:  L Schöls; G Amoiridis; M Langkafel; T Büttner; H Przuntek; O Riess; A M Vieira-Saecker; J T Epplen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

8.  Study of three intragenic polymorphisms in the Machado-Joseph disease gene (MJD1) in relation to genetic instability of the (CAG)n tract.

Authors:  P Maciel; C Gaspar; L Guimarães; J Goto; I Lopes-Cendes; S Hayes; K Arvidsson; A Dias; J Sequeiros; A Sousa; G A Rouleau
Journal:  Eur J Hum Genet       Date:  1999 Feb-Mar       Impact factor: 4.246

9.  Origins of a mutation: population genetics of Machado-Joseph disease in the Azores (Portugal).

Authors:  M Lima; F M Mayer; P Coutinho; A Abade
Journal:  Hum Biol       Date:  1998-12       Impact factor: 0.553

10.  Analysis of SCA1, DRPLA, MJD, SCA2, and SCA6 CAG repeats in 48 Portuguese ataxia families.

Authors:  I Silveira; P Coutinho; P Maciel; C Gaspar; S Hayes; A Dias; J Guimarães; L Loureiro; J Sequeiros; G A Rouleau
Journal:  Am J Med Genet       Date:  1998-03-28
View more
  34 in total

1.  Allele-specific silencing of dominant disease genes.

Authors:  Victor M Miller; Haibin Xia; Ginger L Marrs; Cynthia M Gouvion; Gloria Lee; Beverly L Davidson; Henry L Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-02       Impact factor: 11.205

Review 2.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

3.  Hereditary Ataxias in Cuba: A Nationwide Epidemiological and Clinical Study in 1001 Patients.

Authors:  Luis Velázquez-Pérez; Jacqueline Medrano-Montero; Roberto Rodríguez-Labrada; Nalia Canales-Ochoa; Jandy Campins Alí; Frank J Carrillo Rodes; Tania Rodríguez Graña; María O Hernández Oliver; Raul Aguilera Rodríguez; Yennis Domínguez Barrios; Reydenis Torres Vega; Lissi Flores Angulo; Noharis Y Cordero Navarro; Aldo A Sigler Villanueva; Osiel Gámez Rodríguez; Ilya Sagaró Zambrano; Nayime Y Navas Napóles; Javier García Zacarías; Orlando R Serrano Barrera; María B Ramírez Bautista; Annelié Estupiñán Rodríguez; Leonardo A Guerra Rondón; Yaimeé Vázquez-Mojena; Yanetza González-Zaldivar; Luis E Almaguer Mederos; Alejandro Leyva-Mérida
Journal:  Cerebellum       Date:  2020-04       Impact factor: 3.847

Review 4.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

Review 5.  Machado-Joseph disease/spinocerebellar ataxia type 3.

Authors:  Henry Paulson
Journal:  Handb Clin Neurol       Date:  2012

6.  Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population.

Authors:  Dineke S Verbeek; Bart P C van de Warrenburg; F A M Hennekam; Dennis Dooijes; P F Ippel; Corien C Verschuuren-Bemelmans; H P H Kremer; Richard J Sinke
Journal:  Hum Genet       Date:  2005-04-20       Impact factor: 4.132

Review 7.  Machado-Joseph disease in a Nigerian family: mutational origin and review of the literature.

Authors:  Shamsideen Abayomi Ogun; Sandra Martins; Philip B Adebayo; Clara O Dawodu; Jorge Sequeiros; Michael F Finkel
Journal:  Eur J Hum Genet       Date:  2014-04-30       Impact factor: 4.246

8.  Physiological and pathophysiological characteristics of ataxin-3 isoforms.

Authors:  Daniel Weishäupl; Juliane Schneider; Barbara Peixoto Pinheiro; Corinna Ruess; Sandra Maria Dold; Felix von Zweydorf; Christian Johannes Gloeckner; Jana Schmidt; Olaf Riess; Thorsten Schmidt
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

9.  Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal).

Authors:  Conceição Bettencourt; Raquel Nunes Fialho; Cristina Santos; Rafael Montiel; Jácome Bruges-Armas; Patrícia Maciel; Manuela Lima
Journal:  J Hum Genet       Date:  2008-02-20       Impact factor: 3.172

10.  Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.

Authors:  Mercedes Prudencio; Hector Garcia-Moreno; Karen R Jansen-West; Rana Hanna Al-Shaikh; Tania F Gendron; Michael G Heckman; Matthew R Spiegel; Yari Carlomagno; Lillian M Daughrity; Yuping Song; Judith A Dunmore; Natalie Byron; Björn Oskarsson; Katharine A Nicholson; Nathan P Staff; Sorina Gorcenco; Andreas Puschmann; João Lemos; Cristina Januário; Mark S LeDoux; Joseph H Friedman; James Polke; Robin Labrum; Vikram Shakkottai; Hayley S McLoughlin; Henry L Paulson; Takuya Konno; Osamu Onodera; Takeshi Ikeuchi; Mari Tada; Akiyoshi Kakita; John D Fryer; Christin Karremo; Inês Gomes; John N Caviness; Mark R Pittelkow; Jan Aasly; Ronald F Pfeiffer; Venka Veerappan; Eric R Eggenberger; William D Freeman; Josephine F Huang; Ryan J Uitti; Klaas J Wierenga; Iris V Marin Collazo; Philip W Tipton; Jay A van Gerpen; Marka van Blitterswijk; Guojun Bu; Zbigniew K Wszolek; Paola Giunti; Leonard Petrucelli
Journal:  Sci Transl Med       Date:  2020-10-21       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.